Sign In

Billy Urudra

Chief Commercial Officer (CCO) at Duopharma Biotech Bhd

Billy Urudra is the Executive Director of the Malaysian Organization of Pharmaceutical Industries (MOPI).2 He is based in Shah Alam, Malaysia, and has over 500 connections on LinkedIn.1 Billy is actively involved in the pharmaceutical industry, sharing insights on various topics such as generics market growth, ESG transformation in pharmaceuticals, and biosimilars in Southeast Asia.347

In his role, Billy engages with industry developments, including:

  1. Commenting on the global generics market growth, which reached $321.4bn in 2021 with a 4.5% growth rate.4
  2. Organizing webinars on ESG's impact on the pharmaceutical industry.3
  3. Discussing the potential of biosimilars in Southeast Asia.7
  4. Sharing updates on leadership changes within the industry, such as the appointment of Mr. Ch'ng Kien Peng as a new president.6

Billy also communicates important industry news, such as press statements regarding suppliers of medicines to the Malaysian government.5 His LinkedIn profile suggests he has a background in pharmaceutical industries and studied at Middlesex University.1

Related Questions

What are Billy Urudra's key achievements at CCM Duopharma Biotech Berhad?
How has Billy Urudra contributed to the Malaysian Organisation of Pharmaceutical Industries?
What is Billy Urudra's educational background?
What are Billy Urudra's views on the rise of generics in the pharmaceutical industry?
How does Billy Urudra's experience at GlaxoSmithKline influence his current role?
Billy Urudra
Billy Urudra, photo 1
Billy Urudra, photo 2
Add to my network

Location

Shah Alam, Selangor, Malaysia